MDB Capital Holdings, LLC Stock

Equities

MDBH

US55285N1090

Investment Banking & Brokerage Services

Market Closed - Nasdaq 04:30:00 2024-05-22 pm EDT 5-day change 1st Jan Change
8.734 USD +0.88% Intraday chart for MDB Capital Holdings, LLC -2.96% -24.29%
Sales 2022 1.22M Sales 2023 6M Capitalization 107M
Net income 2022 -5M Net income 2023 -6M EV / Sales 2022 * -
Net cash position 2022 3.53M Net cash position 2023 4.94M EV / Sales 2023 17.1 x
P/E ratio 2022 *
-
P/E ratio 2023
-13.4 x
Employees 40
Yield 2022 *
-
Yield 2023
-
Free-Float 44.48%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.88%
1 week-2.96%
Current month-3.32%
1 month-1.81%
3 months-24.92%
6 months-15.94%
Current year-24.29%
More quotes
1 week
8.51
Extreme 8.51
9.35
1 month
8.02
Extreme 8.02
10.80
Current year
8.00
Extreme 8
13.25
1 year
7.35
Extreme 7.35
21.67
3 years
7.35
Extreme 7.35
21.67
5 years
7.35
Extreme 7.35
21.67
10 years
7.35
Extreme 7.35
21.67
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 96-12-31
President 64 21-08-09
Chief Operating Officer 49 21-08-09
Members of the board TitleAgeSince
Chief Executive Officer 59 96-12-31
Director/Board Member 57 21-08-09
President 64 21-08-09
More insiders
Date Price Change Volume
24-05-22 8.734 +0.88% 1,012
24-05-21 8.657 -1.63% 11,682
24-05-20 8.8 +1.27% 9,774
24-05-17 8.69 -0.69% 2,159
24-05-16 8.75 -2.78% 833

Delayed Quote Nasdaq, May 22, 2024 at 04:30 pm EDT

More quotes
MDB Capital Holdings, LLC is a holding company that has three subsidiaries: MDB CG Management Company (MDB Management), Public Ventures, LLC (Public Ventures), and PatentVest, Inc. (PatentVest), and has a partner company, Invizyne Technologies, Inc. (Invizyne). The Company's segments include broker dealer & intellectual property service, and technology development. The broker dealer & intellectual property service segment has two subsidiaries, Public Ventures and PatentVest. Public Ventures is a full-service broker dealer firm focusing on conducting private and public securities offerings. PatentVest offers in-depth patent research used for investment banking due diligence. The technology development segment has one subsidiary, Invizyne. Invizyne is a research and development stage synthetic biology company. MDB Management is an administrative entity whose purpose is to conduct, and wherever possible, to consolidate shared services/resources, for its United States-based operations.
More about the company